{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:49:42Z","timestamp":1761176982818,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.tracli.2021.08.008","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T10:35:24Z","timestamp":1629542124000},"page":"24-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Positive anti-SARS-CoV-2 rapid serological test results among asymptomatic blood donors"],"prefix":"10.1016","volume":"29","author":[{"given":"Ali","family":"Arabkhazaeli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahtab","family":"Maghsudlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peyman","family":"Eshghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2020","series-title":"Rolling updates on coronavirus disease (COVID-19)","key":"10.1016\/j.tracli.2021.08.008_bib0190"},{"year":"2020","series-title":"Coronavirus disease (COVID-19) pandemic","key":"10.1016\/j.tracli.2021.08.008_bib0195"},{"year":"2020","series-title":"Analysis of epidemic trend by provinces of Iran (till May 29)","author":"CDC NCoC-EaI","key":"10.1016\/j.tracli.2021.08.008_bib0200"},{"year":"2020","series-title":"Q&A on coronaviruses (COVID-19)","key":"10.1016\/j.tracli.2021.08.008_bib0205"},{"key":"10.1016\/j.tracli.2021.08.008_bib0210","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(20)31483-5","article-title":"Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study","volume":"396","author":"Poll\u00e1n","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.tracli.2021.08.008_bib0215","article-title":"Prevalence of SARS-CoV-2 IgG antibodies in an area of North-eastern Italy with a high incidence of COVID-19 cases: a population-based study","author":"Stefanelli","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.tracli.2021.08.008_bib0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.03.004","article-title":"Clinical progression of patients with COVID-19 in Shanghai, China","author":"Chen","year":"2020","journal-title":"Journal of Infection"},{"key":"10.1016\/j.tracli.2021.08.008_bib0225","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1080\/22221751.2020.1744483","article-title":"The different clinical characteristics of corona virus disease cases between children and their families in China\u2013the character of children with COVID-19","volume":"9","author":"Su","year":"2020","journal-title":"Emerging microbes & infections"},{"key":"10.1016\/j.tracli.2021.08.008_bib0230","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2008457","article-title":"Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility","author":"Arons","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2021.08.008_bib0235","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijid.2020.03.020","article-title":"Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)","volume":"94","author":"Nishiura","year":"2020","journal-title":"International journal of infectious diseases"},{"key":"10.1016\/j.tracli.2021.08.008_bib0240","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2488-1","article-title":"Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo\u2019","author":"Lavezzo","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tracli.2021.08.008_bib0245","article-title":"A systematic review of asymptomatic infections with COVID-19, Journal of Microbiology","author":"Gao","year":"2020","journal-title":"Immunology and Infection"},{"key":"10.1016\/j.tracli.2021.08.008_bib0250","doi-asserted-by":"crossref","DOI":"10.1136\/thoraxjnl-2020-215091","article-title":"COVID-19: in the footsteps of Ernest Shackleton","author":"Ing","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.tracli.2021.08.008_bib0255","first-page":"229","article-title":"Asymptomatic Patients with Novel Coronavirus Disease (COVID-19)","volume":"37","author":"An","year":"2020","journal-title":"Balkan medical journal"},{"key":"10.1016\/j.tracli.2021.08.008_bib0260","first-page":"578","article-title":"[Clinical features of asymptomatic or subclinical COVID-19 in children]","volume":"22","author":"Liu","year":"2020","journal-title":"Zhongguo dang dai er ke za zhi=Chinese journal of contemporary pediatrics"},{"key":"10.1016\/j.tracli.2021.08.008_bib0265","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMcp2009249","article-title":"Mild or moderate COVID-19","author":"Gandhi","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2021.08.008_bib0270","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.10.2000180","article-title":"Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020","volume":"25","author":"Mizumoto","year":"2020","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.tracli.2021.08.008_bib0275","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9030789","article-title":"Prediction of the Epidemic Peak of Coronavirus Disease in Japan, 2020","volume":"9","author":"Kuniya","year":"2020","journal-title":"Journal of clinical medicine"},{"key":"10.1016\/j.tracli.2021.08.008_bib0280","doi-asserted-by":"crossref","first-page":"063104","DOI":"10.1063\/1.4922153","article-title":"Numerical identification of epidemic thresholds for susceptible-infected-recovered model on finite-size networks","volume":"25","author":"Shu","year":"2015","journal-title":"Chaos (Woodbury, NY)"},{"key":"10.1016\/j.tracli.2021.08.008_bib0285","first-page":"e46","article-title":"COVID-19 Pneumonia in Asymptomatic Trauma Patients; Report of 8 Cases","volume":"8","author":"Samsami","year":"2020","journal-title":"Archives of academic emergency medicine"},{"key":"10.1016\/j.tracli.2021.08.008_bib0290","doi-asserted-by":"crossref","first-page":"69","DOI":"10.11606\/s1518-8787.2020054002643","article-title":"Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil","volume":"54","author":"Amorim Filho","year":"2020","journal-title":"Revista de saude publica"},{"key":"10.1016\/j.tracli.2021.08.008_bib0295","article-title":"Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors","author":"Erikstrup","year":"2020","journal-title":"Clin Infect Dis"},{"journal-title":"Herd immunity is not a realistic exit strategy during a COVID-19 outbreak","year":"2020","author":"Slot","key":"10.1016\/j.tracli.2021.08.008_bib0300"},{"key":"10.1016\/j.tracli.2021.08.008_bib0305","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.18598","article-title":"Change in Donor Characteristics and Antibodies to SARS-CoV-2 in Donated Blood in the US, June-August 2020","author":"Dodd","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.tracli.2021.08.008_bib0310","doi-asserted-by":"crossref","first-page":"576","DOI":"10.17269\/s41997-021-00531-6","article-title":"SARS-CoV-2 seroprevalence among blood donors in Qu\u00e9bec, and analysis of symptoms associated with seropositivity: a nested case-control study","volume":"112","author":"Lewin","year":"2021","journal-title":"Can J Public Health"},{"key":"10.1016\/j.tracli.2021.08.008_bib0315","doi-asserted-by":"crossref","DOI":"10.3390\/v13071225","article-title":"Seroprevalence of Anti-SARS-CoV-2 Antibodies in Blood Donors from Nuevo Leon State, Mexico, during 2020: A Retrospective Cross-Sectional Evaluation","volume":"13","author":"Martinez-Acu\u00f1a","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.tracli.2021.08.008_bib0320","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.3201\/eid2707.203167","article-title":"Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UK","volume":"27","author":"Amirthalingam","year":"2021","journal-title":"Emerging infectious diseases"},{"key":"10.1016\/j.tracli.2021.08.008_bib0325","doi-asserted-by":"crossref","first-page":"103118","DOI":"10.1016\/j.transci.2021.103118","article-title":"Seroprevalence of SARS-Coronavirus 2 among asymptomatic healthy blood donors from healthcare and non-healthcare settings: Implications for safety of blood donors and blood collection staff during blood donation","volume":"60","author":"Pandey","year":"2021","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2021.08.008_bib0330","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijid.2020.03.050","article-title":"Monitoring transmissibility and mortality of COVID-19 in Europe","volume":"95","author":"Yuan","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.tracli.2021.08.008_bib0335","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(20)31304-0","article-title":"Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study","volume":"396","author":"Stringhini","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.tracli.2021.08.008_bib0340","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(20)30985-5","article-title":"What policy makers need to know about COVID-19 protective immunity","volume":"395","author":"Altmann","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.tracli.2021.08.008_bib0345","article-title":"Obesity is a potential risk factor for covid-19 associated morbidity and mortality in urban Bangladesh","volume":"370","author":"Ahmed","year":"2020","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.tracli.2021.08.008_bib0350","article-title":"Characteristics and clinical outcomes of COVID-19 patients in an underserved-inner city population: A single tertiary center cohort","author":"Salacup","year":"2020","journal-title":"Journal of medical virology"},{"key":"10.1016\/j.tracli.2021.08.008_bib0355","article-title":"Genomewide Association Study of Severe Covid-19 with Respiratory Failure","author":"Ellinghaus","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2021.08.008_bib0360","doi-asserted-by":"crossref","first-page":"102581","DOI":"10.1016\/j.amjoto.2020.102581","article-title":"COVID-19 and anosmia: A review based on up-to-date knowledge","volume":"41","author":"Meng","year":"2020","journal-title":"American journal of otolaryngology"},{"key":"10.1016\/j.tracli.2021.08.008_bib0365","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0194599820926473","article-title":"The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis","volume":"163","author":"Tong","year":"2020","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.tracli.2021.08.008_bib0370","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s12879-020-05144-x","article-title":"Risk factors for disease progression in COVID-19 patients","volume":"20","author":"Chang","year":"2020","journal-title":"BMC infectious diseases"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782021001221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782021001221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:39:53Z","timestamp":1761129593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782021001221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1246782021001221"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2021.08.008","relation":{},"ISSN":["1246-7820"],"issn-type":[{"type":"print","value":"1246-7820"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positive anti-SARS-CoV-2 rapid serological test results among asymptomatic blood donors","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2021.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}